Stericycle, Inc. (NASDAQ:SRCL) Shares Sold by PNC Financial Services Group Inc.

PNC Financial Services Group Inc. reduced its position in shares of Stericycle, Inc. (NASDAQ:SRCL) by 5.2% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 22,899 shares of the business services provider’s stock after selling 1,244 shares during the period. PNC Financial Services Group Inc.’s holdings in Stericycle were worth $1,135,000 as of its most recent SEC filing.

Other institutional investors and hedge funds have also made changes to their positions in the company. Vanguard Group Inc. grew its stake in Stericycle by 0.6% during the 4th quarter. Vanguard Group Inc. now owns 8,969,118 shares of the business services provider’s stock valued at $444,509,000 after purchasing an additional 52,576 shares in the last quarter. Sei Investments Co. increased its stake in shares of Stericycle by 35.5% in the fourth quarter. Sei Investments Co. now owns 1,061,369 shares of the business services provider’s stock worth $52,601,000 after buying an additional 277,896 shares during the last quarter. Natixis Investment Managers International raised its holdings in Stericycle by 23.6% in the fourth quarter. Natixis Investment Managers International now owns 3,207 shares of the business services provider’s stock valued at $159,000 after acquiring an additional 612 shares in the last quarter. Thematics Asset Management boosted its stake in Stericycle by 15.1% during the 4th quarter. Thematics Asset Management now owns 492,471 shares of the business services provider’s stock valued at $24,407,000 after acquiring an additional 64,471 shares during the last quarter. Finally, Schroder Investment Management Group grew its holdings in Stericycle by 8.1% during the 4th quarter. Schroder Investment Management Group now owns 1,739,644 shares of the business services provider’s stock worth $86,217,000 after acquiring an additional 129,822 shares in the last quarter. 98.82% of the stock is currently owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

Several equities analysts have recently commented on SRCL shares. Wells Fargo & Company increased their price target on shares of Stericycle from $40.00 to $48.00 and gave the stock an “underweight” rating in a research report on Friday, March 1st. Truist Financial raised their target price on shares of Stericycle from $50.00 to $62.00 and gave the stock a “hold” rating in a report on Tuesday, June 4th. StockNews.com started coverage on Stericycle in a report on Friday. They set a “hold” rating for the company. Robert W. Baird cut their price target on Stericycle from $62.00 to $55.00 and set a “neutral” rating on the stock in a report on Friday, April 26th. Finally, Stifel Nicolaus upped their price objective on Stericycle from $70.00 to $75.00 and gave the stock a “buy” rating in a research note on Thursday, February 29th. One equities research analyst has rated the stock with a sell rating, four have given a hold rating and two have issued a buy rating to the company’s stock. According to MarketBeat.com, the stock has a consensus rating of “Hold” and a consensus price target of $74.00.

Stericycle Trading Down 0.3 %

Shares of SRCL stock opened at $57.56 on Monday. The firm has a market capitalization of $5.34 billion, a PE ratio of -261.64, a price-to-earnings-growth ratio of 3.11 and a beta of 1.08. The stock has a fifty day moving average of $50.92 and a two-hundred day moving average of $50.49. Stericycle, Inc. has a 1 year low of $37.78 and a 1 year high of $59.45. The company has a debt-to-equity ratio of 0.55, a quick ratio of 1.11 and a current ratio of 1.11.

Stericycle (NASDAQ:SRCL) last announced its earnings results on Thursday, April 25th. The business services provider reported $0.57 EPS for the quarter, topping the consensus estimate of $0.54 by $0.03. The firm had revenue of $664.90 million for the quarter, compared to analysts’ expectations of $676.42 million. Stericycle had a positive return on equity of 7.31% and a negative net margin of 0.74%. The firm’s quarterly revenue was down 2.8% compared to the same quarter last year. During the same quarter in the previous year, the company earned $0.49 earnings per share. As a group, research analysts expect that Stericycle, Inc. will post 2.32 EPS for the current year.

Stericycle Profile

Stericycle, Inc, together with its subsidiaries, provides regulated waste and compliance services in the United States, Europe, and internationally. The company offers regulated waste and compliance services, including regulated medical waste, sharps waste management and disposal, pharmaceutical waste management and disposal, chemotherapy waste and disposal, controlled substance waste disposal, healthcare hazardous waste, and integrated waste stream solutions; specialty services, such as MedDrop medication collection kiosks, safe community solutions, SafeDrop sharps mailback solutions, and airport and maritime waste services; medical supply store services, that includes sharps and disposable biohazardous waste containers, infection control supplies, and seal&send medication mail back; and compliance solutions including Steri-Safe compliance solutions.